Release of ADA 2018 Standards with new recommendations for diabetes patients with CVDNews - Dec. 12, 2017
The ADA Standards of Medical Care in Diabetes provide clinicians, patients, researchers, health plans and policymakers with the most up-to-date insights on diabetes care, general treatment goals and tools to evaluate the quality of care. Important changes and updates in the 2018 edition include:
- Based upon the results of multiple cardiovascular outcome trials, there are new treatment recommendations for type 2 diabetes patients with CVD, including hypertension. The results of randomized controlled trials support the ADA’s recommendation that most adults with hypertension should have a target blood pressure <140/90 mmHg and lower targets may be appropriate for some patients; a new algorithm illustrates the recommended antihypertensive treatment approach in patients with type 2 diabetes. In addition, it is recommended that all hypertensive patients with diabetes should monitor their blood pressure at home.
- Routine screening for prediabetes and type 2 diabetes should be considered in children and adolescents younger than 18 years of age who are at high risk (BMI >85th percentile plus at least one additional risk factor).
- Recommendations are provided for integration of new technology into diabetes management for effective self-management education and support and for continuous glucose monitoring (CGM).
- Additional language and recommendations have been added to help ensure appropriate use of the HbA1C test to diagnose diabetes and to monitor glycemic control in people with diabetes.
- Recommendations for diabetes management in specific subgroups, such as older adults and pregnant women with preexisting type 1 or 2 diabetes, were added.
- Drug-specific and patient factors that may impact treatment were summarized and recommendations for increased awareness of and screening for social determinants of health were made.